Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound Paclitaxel vs Cisplatin with Radiotherapy in Early Nasopharyngeal Carcinoma
NCT04766359Phase 3Unknown
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Mar 2021
- Primary completion
- Aug 2025
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
A Phase 3 trial of nab-paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Nanjing Drum-Tower Hospital. Status: unknown.
02
Drugs
nab-paclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04766359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766359.